Skip to main content

Table 2 Statistical significance of serum pulmonary functions before and after receiving treatment showing the differences between asthmatic bronchitis patients at mild and severe stages as compared to control

From: Biochemical and electrophoretic study for diagnosis of the disease stage in patients with asthmatic bronchitis

 

Control

Asthmatic bronchitis patients

Mild

Severe

Pre-treatment

FEV1

0.95 ± 0.004

0.62 ± 0.03a

0.62 ± 0.04b

FVC

0.92 ± 0.003

0.81 ± 0.04a

0.75 ± 0.03a

FEV1/FVC%

0.85 ± 0.004

0.70 ± 0.02a

0.68 ± 0.04a

MEF25-75

1.10 ± 0.02

0.33 ± 0.04a

0.30 ± 0.04a

Post-treatment

FEV1

1.11 ± 0.01

0.75 ± 0.04a

0.74 ± 0.04a

FVC

1.11 ± 0.01

0.89 ± 0.04a

0.82 ± 0.03a

FEV1/FVC%

0.97 ± 0.003

0.84 ± 0.02a

0.82 ± 0.04a

MEF25-75

1.28 ± 0.02

0.43 ± 0.05a

0.41 ± 0.05a

  1. Values are expressed as mean ± SE. aSignificant difference as compared to control (P < 0.05), bSignificant difference as compared to patients at mild stage (P < 0.05)